A new study reveals important molecular information that could help scientists develop more effective treatment and prevention strategies for a difficult-to-treat form of melanoma skin cancer.
Jun 23, 2022
0
26
Breast cancers with HER2 mutations respond to the drug neratinib, but the responses are variable and often not durable. Looking to better understand the underlying cause of this variation, a team led by researchers at Baylor ...
Jun 23, 2022
0
6
The lab of Kathy DelGiorno, assistant professor of cell and developmental biology, seeks to understand changes in the pancreas in response to injury and disease. In a recent project led by graduate student Leah Caplan, also ...
Jun 17, 2022
0
14
Reducing the burden of cancer in individuals and society is a major area of concern globally. In Norway, by the end of 2020, 35,515 people were newly diagnosed with cancer and more than 300,000 people were already living ...
Jun 16, 2022
0
10
Researchers at The University of Texas MD Anderson Cancer Center have developed a new approach to quantify tumor-specific total mRNA levels from patient tumor samples, which contain both cancer and non-cancer cells. Using ...
Jun 13, 2022
0
28
A new study that analyzed protein levels in 2,002 primary tumors from 14 tissue-based cancer types identified 11 distinct molecular subtypes, providing systematic knowledge that greatly expands a searchable online database ...
Jun 10, 2022
0
35
A stress protein that is overactive in many types of tumor cells also has a key role in tumor-supporting cells called fibroblasts, and may be a good target for future cancer treatments, suggests a study from researchers at ...
Jun 6, 2022
0
90
A compound, developed by a team including scientists from The University of Texas Health Science Center at San Antonio, kills a range of hard-to-treat cancer types in petri dishes and animal models by targeting a previously ...
Jun 2, 2022
0
1092
In a novel experiment, a woman with advanced pancreatic cancer saw her tumors dramatically shrink after researchers in Oregon turbocharged her own immune cells, highlighting a possible new way to someday treat a variety of ...
Jun 2, 2022
0
307
A new large national study led by researchers at the American Cancer Society (ACS) shows the mortality risk from cardiovascular disease (CVD) differs considerably among cancer survivors by race/ethnicity and cancer types. ...
May 31, 2022
0
1
